Condition
Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid Glands
Total Trials
2
Recruiting
0
Active
2
Completed
0
Key Insights
Highlights
Treatment Research
5 treatments under study, led by Aav2haqp1 Concentration 1
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Phase 2 (2)
Trial Status
Active Not Recruiting1
Enrolling By Invitation1
Clinical Trials (2)
Research Network
Common Treatments
- Aav2haqp1 Concentration 11
- Aav2haqp11
- Aav2haqp1 Concentration 31
- Aav2haqp1 Concentration 21
- Aav2haqp1 Concentration 41
Active Sponsors
- MeiraGTx, LLC2